Management of MRSA Wound Infections

Initial Management and First-Line Oral Antibiotic Options

The American College of Physicians recommends surgical drainage and debridement as the mainstay of therapy for MRSA wound infections, which must be performed whenever feasible before or concurrent with antibiotic therapy, with a treatment duration of 5-10 days for uncomplicated infections 1, 2
For patients with normal renal function, the Infectious Diseases Society of America recommends trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets (160-320/800-1600 mg) orally twice daily as the first-line oral antibiotic, with bactericidal activity against MRSA 1, 3
The Centers for Disease Control and Prevention suggest doxycycline 100 mg orally twice daily as an alternative first-line option, equally effective as TMP-SMX with similar streptococcal coverage limitations 1, 2, 4
Clindamycin 300-450 mg orally three times daily provides dual coverage for both MRSA and streptococci as a single agent, but its use is recommended only if local MRSA resistance rates are <10% due to inducible resistance concerns 1, 2, 3, 4

The American College of Physicians recommends a treatment duration of 5-10 days for uncomplicated MRSA wound infections and 7-14 days for complicated infections, with reassessment clinically within 48-72 hours to ensure appropriate response 1, 2
For patients requiring dual coverage for both MRSA and beta-hemolytic streptococci, the Infectious Diseases Society of America suggests using clindamycin alone (if local resistance <10%) or combining TMP-SMX or doxycycline with a beta-lactam (cephalexin 500 mg four times daily or amoxicillin) 1, 2, 4

The Centers for Disease Control and Prevention advise against using beta-lactam antibiotics (amoxicillin, cephalexin, dicloxacillin) alone for MRSA, as they have zero activity against methicillin-resistant organisms, and against using fluoroquinolones as monotherapy due to high MRSA resistance rates 1, 4
The American College of Physicians recommends avoiding clindamycin if local MRSA resistance exceeds 10% or if inducible resistance is detected on susceptibility testing, and never using rifampin as monotherapy or routinely adding it to other antibiotics for wound infections due to rapid development of resistance 2, 3, 4

Incision and drainage is the mainstay of therapy and must be performed before or concurrent with antibiotic therapy for any abscess or purulent wound infection, as recommended by the Infectious Diseases Society of America 5
For simple abscesses without systemic signs of infection, incision and drainage alone may be adequate without antibiotics, according to the Infectious Diseases Society of America 5
If dual coverage for MRSA and beta-hemolytic streptococci is needed, combine TMP-SMX or doxycycline with a beta-lactam, or use clindamycin alone if local resistance is <10%, as suggested by the Infectious Diseases Society of America 5
Systemic signs requiring antibiotics include temperature ≥38°C, tachycardia, tachypnea, abnormal white blood cell count, and immunocompromised state, as defined by the Infectious Diseases Society of America 5
Minocycline may be more reliable than doxycycline for community-acquired MRSA, with consistent clinical efficacy, according to the Infectious Diseases Society of America 6